Bactana’s microbiome discovery platform enables development of products and therapeutics through the use of recent advances in molecular and DNA sequencing methods used to study microbial ecology. This platform allows Bactana to concentrate its product development on the interaction of an animal’s microbiome with its immune system & metabolism (immunometabolism) at an accelerated pace. Bactana’s initial focus is on its patented FPS-4™ product line which is supported by multiple calf trials that have demonstrated scours reduction, increased milk production, reduced mortality, improved feed efficiency, and growth. FPS-4 is expected to provide similar benefits for swine, poultry, and other animals. Bactana has developed a breakthrough product with FPS-4 and will continue making new discoveries related to the animal microbiome.
Our proprietary development platform, FPS-4, is based on the beneficial manipulation of the interaction between an animal’s
immune system and their metabolism (immunometabolism) in order to boost productivity while promoting good health.
– John Kallassy, chief executive officer
WHAT MOTIVATES US?
Global demand for high quality animal products continue to grow, especially in emerging markets. As a result, livestock producers around the globe are being called upon to produce more with fewer resources – all while maintaining a commitment to ethical and sustainable farming. It is generally accepted among the scientific community that antibiotic use in animals contributes to human resistance, posing a significant public health threat.
Bactana is working to overcome these problems by delivering safe, effective and inexpensive alternatives to antibiotics.